Stay updated on Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added the 'Results Submitted' status and updated the page revision to v3.4.3, replacing the previous 'No Results Posted' status and v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T18:55:20.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The institution name was updated from Sidney Kimmel Cancer Center at Thomas Jefferson University to Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
    Difference
    0.0%
    Check dated 2026-02-25T11:47:39.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Added revision note: v3.4.2. Removed prior funding-status notice and revision note v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T10:32:10.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide funding/status notice indicating potential delays and that the NIH Clinical Center is open. The page revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:22:39.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and updated metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the earlier entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T04:20:49.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study details, eligibility criteria, or other core content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:16:03.000Z thumbnail image

Stay in the know with updates to Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.